Company Name: |
Shanghai YuanYe Biotechnology Co., Ltd.
|
Tel: |
021-61312847; 18021002903 |
Email: |
3008007409@qq.com |
Products Intro: |
Product Name:Vofatamab (anti-FGFR3) CAS:1312305-12-6 Purity:ExactAb?, Validated, Carrier Free, Low Endotoxin, Azide Free Package:100μg Remarks:K13821
|
Company Name: |
ShangHai Biochempartner Co.,Ltd
|
Tel: |
17754423994 17754423994 |
Email: |
2853530910@QQ.com |
Products Intro: |
Product Name:Vofatamab CAS:1312305-12-6 Purity:95% Package:100ug;500ug;1mg
|
Company Name: |
Guangzhou Hongyuan Chemical Co.,Ltd
|
Tel: |
15817493340 |
Email: |
981810490@qq.com |
Products Intro: |
Product Name:Vofatamab CAS:1312305-12-6 Purity:95% Package:1mg;1g;100g
|
Vofatamab manufacturers
- Vofatamab
-
- $339.00 / 1mg
-
2025-05-05
- CAS:1312305-12-6
- Min. Order:
- Purity: > 95%
- Supply Ability: 10g
|
| Vofatamab Basic information |
Product Name: | Vofatamab | Synonyms: | Vofatamab;Research Grade Vofatamab(DHD52901);RG-7444|||B-701|||MFGR-1877S;Research Grade Vofatamab;Vofatamab (anti-FGFR3) | CAS: | 1312305-12-6 | MF: | | MW: | 0 | EINECS: | | Product Categories: | | Mol File: | Mol File | ![Vofatamab Structure]() |
| Vofatamab Chemical Properties |
form | Liquid | color | Colorless to light yellow |
| Vofatamab Usage And Synthesis |
Uses | Vofatamab (B-701) is an anti-FGFR3 monoclonal antibody (mAb). Vofatamab blocks activation of both the wildtype and genetically activated receptor. Vofatamab can be used in the research of metastatic urothelial carcinoma (mUC)[1]. | IC 50 | FGFR3 | References | [1] Andrea Necchi, et al. Fierce-21: Phase II study of vofatmab (B-701), a selective inhibitor of FGFR3, as salvage therapy in metastatic urothelial carcinoma (mUC). Journal of Clinical Oncology 2019 37:7_suppl, 409-409. |
| Vofatamab Preparation Products And Raw materials |
|